A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease - Jennifer Mitchell (ClinicalTrials.gov, 2026)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com